NIH – MPP, COVID-19 Patent and Biological Material License Agreement

• Post author:GHIAA Admin
• Post published:June 29, 2022
• Post category:

Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement

Boston University Startup Exclusive License Template

• Post author:GHIAA Admin
• Post published:June 7, 2022
• Post category:

Continue ReadingBoston University Startup Exclusive License Template

Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement

• Post author:GHIAA Admin
• Post published:May 31, 2022
• Post category:

Continue ReadingElkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement

CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

• Post author:GHIAA Admin
• Post published:May 23, 2022
• Post category:

Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

BMGF – Arsanis RSV Monoclonal Antibodies Funding Agreement

• Post author:GHIAA Admin
• Post published:April 25, 2022
• Post category:

Continue ReadingBMGF – Arsanis RSV Monoclonal Antibodies Funding Agreement

Cellscript – BioNTech mRNA Technology Patent Sublicense

• Post author:GHIAA Admin
• Post published:March 17, 2022
• Post category:

Continue ReadingCellscript – BioNTech mRNA Technology Patent Sublicense

Biological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement

• Post author:GHIAA Admin
• Post published:March 3, 2022
• Post category:

Continue ReadingBiological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement

Gavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement

• Post author:GHIAA Admin
• Post published:February 2, 2022
• Post category:

Continue ReadingGavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement

CEPI – Dynavax, COVID-19 Material Reservation Agreement

• Post author:GHIAA Admin
• Post published:January 31, 2022
• Post category:

Continue ReadingCEPI – Dynavax, COVID-19 Material Reservation Agreement